BIIB Archives - Spark Newswire

2 minute read

Eli Lilly’s Donanemab Gains Favorable FDA Advisory Verdict, Boosting Stock Potential, Says BofA Analyst

June 11, 2:19 PM

Eli Lilly's donanemab for Alzheimer's disease garners positive FDA committee verdict, prompting analyst's bullish outlook amid comparisons to Biogen's Leqembi.

BIIB

2 minute read

Why Is Eli Lilly Stock Trading Higher Premarket Tuesday?

By Shivani Kumaresan

June 11, 7:51 AM

Shares of Eli Lilly surged as an FDA advisory committee endorsed donanemab, an Alzheimer's treatment shown to significantly impact early-stage patients. The drug's benefits outstripped risks, setting the stage for a final FDA decision.

BIIB

1 minute read

FDA
News

Eisai And Biogen Announced FDA Accepts Filing of LEQEMBI Supplemental Biologics License Application For IV Maintenance Dosing To Treat Early Alzheimer’s Disease

By Benzinga Newsdesk

June 9, 8:09 PM

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (NASDAQ:BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, "Biogen")) announced today that the U.S.Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc.

BIIB

2 minute read

(BIIB) – Analyzing Biogen’s Short Interest

By Benzinga Insights

June 7, 11:15 AM

Biogen’s (NYSE:BIIB) short percent of float has risen 10.25% since its last report. The company recently reported that…

BIIB

2 minute read

Movers
News

Biogen Shares Surge Following Collaboration With Delta Flight Products: What You Need To Know

By Vaishali Prayag

June 3, 2:43 PM

Biogen Inc. (NASDAQ: BIIB) shares saw a notable uptick Monday afternoon, trading higher after the company revealed a new partnership with Delta Flight Products (DFP) to enhance air travel accessibility for passengers with reduced mobility.

BIIB

5 minute read

Options

10 Health Care Stocks With Whale Alerts In Today’s Session

By Benzinga Insights

June 3, 1:35 PM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums…

BIIB

2 minute read

Europe Approves Biogen’s Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder

By Vandana Singh

May 31, 10:25 AM

The European Commission has granted exceptional marketing authorization for Biogen's Qalsody (tofersen), the first EU-approved treatment targeting the genetic cause of ALS.

BIIB

4 minute read

Analyst Ratings

Deep Dive Into Biogen Stock: Analyst Perspectives (17 Ratings)

By Benzinga Insights

May 22, 10:00 AM

Analysts’ ratings for Biogen (NASDAQ:BIIB) over the last quarter vary from bullish to bearish, as provided by 17…

BIIB

2 minute read

Larimar Therapeutics’ Friedreich’s Ataxia Investigational Drug Differentiated From Biogen’s Marketed Drug

By Vandana Singh

May 21, 2:39 PM

Larimar Therapeutics announces FDA lift of partial clinical hold on nomlabofusp (CTI-1601) for Friedreich's Ataxia. Data from Phase 2 study shows well-tolerated treatment with significant frataxin level increases.

BIIB

2 minute read

How Is The Market Feeling About Biogen?

By Benzinga Insights

May 20, 4:45 PM

Biogen’s (NYSE:BIIB) short percent of float has fallen 3.56% since its last report. The company recently reported that…

BIIB

Feed Symbols: BIIB